|
Delayed
NSE India S.E.
10:44:42 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.36 INR | +0.19% |
|
-3.72% | -46.63% |
Business description: Nectar Lifesciences Limited

Number of employees: 111
Sales by Activity: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals Products | 16.69B | 15.24B | 16.85B | 16.7B | - |
Geographical breakdown of sales: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 11.81B | 8.45B | 11.46B | 11.72B | - |
Outside India | 7.45B | 9.01B | 7.79B | 7.37B | - |
Executive Committee: Nectar Lifesciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 14/11/2022 |
| Compliance Officer | - | 01/04/2025 |
Composition of the Board of Directors: Nectar Lifesciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 27/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 11/02/2019 |
| Director/Board Member | 75 | 21/09/2021 | |
Indu Pal Kaur
BRD | Director/Board Member | 61 | 02/08/2022 |
Company details: Nectar Lifesciences Limited

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | -3.72% | -34.26% | -55.05% | 21.09M | ||
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | ||
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | ||
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | ||
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | ||
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | ||
| +0.34% | +1.84% | +30.70% | +54.27% | 294B | ||
| -0.45% | +1.19% | +2.89% | +26.08% | 264B | ||
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | ||
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | ||
| Average | +0.16% | +0.41% | +33.15% | +63.26% | 403.72B | |
| Weighted average by Cap. | +0.26% | +1.50% | +44.52% | +89.10% |
- Stock Market
- Stocks
- NECLIFE Stock
- Company Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions

















